Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

An example of its marketing success would be the recent Superbowl ad campaign, which reverberated through the entire healthcare industry. According to EDO, HIMS' Super Bowl ad drove 7.7x as much ...

Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) plummeted following its fourth-quarter earnings report. The stock had ...

Recently launched key healthcare solutions OpenText will showcase at HIMSS include: OpenText™ Core Messaging, a Communications Platform as a Service (CPaaS) solution that delivers unified ...

From Integrating Real-Time Pharmacogenomics to Boosting Medication Adherence, Healthcare Organizations Are Realizing the Benefits of Advanced Medication Decision Support At FDB booth #2835 in the ...

Earlier this month, Hims ran a Super Bowl ad touting the affordability of its weight loss drugs compared to those sold by big pharmaceutical companies. The ad sparked controversy for promoting ...

"Our Netsmart team has continued to have a strong presence at HIMSS, and we are thrilled to highlight the work we've been doing alongside this group of interoperability industry leaders to achieve ...

Altera Digital Health (booth #2532), a global health IT leader, will exhibit at the Health Information Management Systems Society (HIMSS) 2025 Global Conference in Las Vegas, Nevada, March 3–6 ...

Hims & Hers Health beat fourth-quarter estimates and guided for better-than-expected revenue in the first quarter and 2025. The telehealth provider logged earnings of 11 cents a share on revenue ...